Vascular surgeon Coleman receives funding support for global collaborative on pediatric renovascular hypertension

January 22, 2021  //  FOUND IN: Our Employees
Coleman

Dawn Coleman, M.D., will formalize a patient-centered outcomes research global collaborative to improve the care of children with a rare disease. It’s thanks to new funding through the Eugene Washington PCORI Engagement Awards program, an initiative of the Patient-Centered Outcomes Research Institute (PCORI).

Coleman, a vascular surgeon at the Michigan Medicine Frankel Cardiovascular Center and co-director of the U-M pediatric renovascular hypertension center, cares for patients with pediatric renovascular hypertension alongside a multidisciplinary group. Meanwhile, she and Santhi Ganesh, M.D., perform research to further understanding. In 2019, they co-hosted a symposium dedicated to advancing collaboration and knowledge about the disease among clinicians and researchers worldwide, with the support of the Taubman Institute.

“Pediatric renovascular hypertension is a rare and complex condition. The etiology for most cases remains unclear, optimal management often ill-defined, and the expansion of novel surgical and endovascular techniques continues to change the landscape of patient care,” said Coleman, an associate professor of surgery and pediatrics.

“At Michigan Medicine, we are excited and grateful to continue this collaborative research journey with our global partners in a way that will prioritize the voice of the patients and families affected by this disease, as supported by this Patient-Centered Outcomes Research Institute award.  This comes at a critical time when there has been remarkable growth of our multidisciplinary clinical program at U-M, and with the formation of the multidisciplinary Pediatric Renovascular Hypertension Program.”

Coleman’s funding is one of a portfolio of projects that PCORI has funded to help develop a community of patients and other stakeholders equipped to participate as partners in comparative clinical effectiveness research and disseminate PCORI-funded study results. Through the Engagement Award Program, PCORI is creating an expansive network of individuals, communities and organizations interested in and able to participate in, share, and use patient-centered clinical effectiveness research.

According to Jean Slutsky, PCORI’s chief engagement and dissemination officer, “This project was selected for Engagement Award funding because it will build a community equipped to participate as partners in clinical effectiveness research and develop partnerships and infrastructure to disseminate PCORI-funded research results. We look forward to working with Michigan Medicine throughout the course of their project.”

For more information about PCORI’s funding to support engagement efforts, visit http://www.pcori.org/content/eugene-washington-pcori-engagement-awards/.

PCORI is an independent, nonprofit organization authorized by Congress in 2010 to fund comparative effectiveness research that will provide patients, their caregivers, and clinicians with the evidence needed to make better-informed health and healthcare decisions. PCORI is committed to seeking input from a broad range of stakeholders to guide its work.

This program was funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (Contract # 19976-UM).

RELATED STORIES